Detection of residual tissue after thyroidectomy for papillary or follicular thyroid carcinoma
may be performed using diagnostic imaging with either 123I or 131I. The former is often …

Thyroid stunning is a radiobiological phenomenon observed when a relatively high dose of
1–131 is used for diagnostic purposes before radioablation therapy for patients with well …

One of the fundamentals of treating patients with cancer is knowing the extent of disease as
precisely as possible. This applies in cancers of the breast, lung, bowel, pancreas, and …

Debates regarding thyroid stunning—a phenomenon whereby a diagnostic dose of
radioiodine decreases uptake of a subsequent therapeutic dose by remnant thyroid tissue or …

In the thyroid cancer, I-131 scan is useful for evaluation of the remnant or functional
metastasis. But in the low dose scan, there could be false negative. Also in the high dose …

This study was performed to determine differences in 123I image quality at 5 and 24 h for the
detection of residual thyroid or recurrent disease in patients with differentiated thyroid cancer …

Radioiodine has been used in the management of thyroid cancer for 60 years [1]. It has a
diagnostic role in patients with differentiated thyroid cancer who have been treated by …

Aim: The specific excretion pathways of iodine may cause several diagnostic pitfalls.
Information concerning their relative frequency and possible consequences in daily routine …

Background The aim was to compare the detect ability of three sequential 131I whole-body
scans (tri-WBS) on the second, third, and fourth day after 131I therapy for metastatic thyroid …

TO THE EDITOR: Dorn et al. have described a dosimetryguided approach for calculating the
largest “safe” dose of 131I for treatment of differentiated thyroid cancer (1). With this method …